Andy Blauvelt, MD, MBA: Safety Data on JAK Inhibitors for Atopic Dermatitis

January 26, 2023

Dr. Blauvelt discusses his presentation at Maui Derm 2023, in which he compares new safety data for JAK inhibitors in atopic dermatitis treatment with data from older JAK inhibitors historically used for other diseases.

More Maui Derm 2023 Video Coverage

Michael Gold, MD: Laser and Light Session at Maui Derm 2023

Dr. Gold recaps his presentation from the “Lasers, Lights, Radiofrequency,...

Joel Cohen, MD: Heavy Laser Resurfacing

Dr. Cohen discusses his strategies for heavy laser resurfacing for...

Joel Cohen, MD: New Lasers for Acne Treatment

Dr. Cohen discusses the 1726 nm laser for the treatment...

Raj Chovatiya, MD, PhD: Exceptional Eczematous Expertise

Dr. Chovatiya recaps his session from Maui Derm 2023, in...

Sheila Fallon Friedlander, MD: What’s New in Pediatric Dermatology

xx...

Sheila Fallon Friedlander, MD: Literature Update 2023 in Pediatric Dermatology

Dr. Friedlander summarizes the most notable additions to the pediatric...

Phil Werschler, MD: Cosmetic Dermatology Sessions at Maui Derm 2023

Dr. Werschler provides an overview of the cosmetic dermatology sessions...

Dee Anna Glaser, MD: Emerging Toxins and Fillers in 2023

Dr. Glaser discusses exciting new toxins and fillers to look...

Suneel Chilukuri, MD: What’s New in Toxins, Fillers, and Aesthetic Devices

Dr. Chilukuri recaps his “What’s my Treatment?” presentation delivered at...

Ted Rosen, MD: New Drugs and Devices at Maui Derm 2023

Dr. Rosen recaps his New Drugs and Devices session delivered...

Ted Rosen, MD: What’s New in Actinic Keratoses

Dr. Rosen discusses new methods for the treatment and prevention...

Seemal Desai, MD: Challenging Cases

Dr. Desai recaps his Challenging Cases session from Maui Derm...

John Harris, MD, PhD: Developments in JAK Inhibitors for Vitiligo

Dr. Harris discusses the recent research milestones achieved in the...

Lawrence Eichenfield, MD: What’s New in Pediatric Atopic Dermatitis

Dr. Eichenfield recaps his Maui Derm 2023 presentation, in which...

Ava Shamban, MD: Improving Injection Patterns with Daxibotulinumtoxina

Dr. Shamban recaps her Maui Derm 2023 presentation delivered during...

Daniel Siegel, MD: Coding and Reimbursement

Dr. Siegel discusses his Maui Derm 2023 presentation, “How To...

Leon Kircik, MD: JAK Inhibitors in Dermatology

Dr. Kircik provides an overview of the current landscape of...

Lawrence Eichenfield, MD: What’s New in Pediatric Acne

Dr. Eichenfield discusses his presentation from Maui Derm 2023 that...

Matthew Zirwas, MD: Contact Dermatitis Update 2023

Dr. Zirwas provides the main takeaways from his contact dermatitis...

Dr. Zirwas reviews new advancements in systemics for atopic dermatitis...

Neal Bhatia, MD: New Therapies in the Field of Dermatology

Dr. Bhatia reviews an array of new therapies discussed during...

Neal Bhatia, MD: New Opportunities for JAK Inhibitors

Dr. Bhatia gives an overview of the utilization of JAK...

Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata

Dr. Bhatia details the recent approval of Ritlecitinib which is...

Linda Stein Gold, MD: Exploring the Impact of Novel TYK2 Inhibitors in Plaque Psoriasis

Dr. Stein Gold discusses her presentation at Maui Derm 2023...

Linda Stein Gold, MD: Biggest Misconceptions Regarding Mild-to-Moderate Psoriasis

Dr. Stein Gold discusses various misconceptions of localized psoriasis and...

Mark Kaufmann, MD: How to Maximize Your Billing Effectiveness In The Era of Dwindling Reimbursements and ICD-10

Dr. Kaufmann reviews his session regarding coding and reimbursement issues...